MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Cardiovascular, Cardiac & Cardiology Companies _ Pharmaceutical & Biotechnology
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD)*
Organization & Developments: Cadrenal Therapeutics
Parents
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD)*
Children
2022: Cadrenal Therapeutics Proposes $10 Million IPO Terms
Founded to acquire and develop tecarfarin, which has been previously developed by Espero BioPharma
The firm is developing an anticoagulant drug treatment for various cardiovascular conditions
Jumps
Finance & Acquisition: Cadrenal Therapeutics
Key People: Cadrenal Therapeutics